{"id":466,"date":"2014-10-08T11:20:48","date_gmt":"2014-10-08T11:20:48","guid":{"rendered":"https:\/\/blogs.bmj.com\/jnnp\/?p=466"},"modified":"2014-10-08T11:20:48","modified_gmt":"2014-10-08T11:20:48","slug":"cholinesterase-inhibitors-in-parkinsons-disease","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/","title":{"rendered":"Cholinesterase inhibitors in Parkinsons disease?"},"content":{"rendered":"<p>Cholinesterase inhibitors (ChIs) improve cholinergic transmission and thereby may lead to improved cognitive function in PD, although the risk of side-effects such as falls may be potentially increased.\u00a0 In an upcoming issue of JNNP (On line first)\u00a0 Pagano and colleagues conducted a meta-analysis to further assess these issues.\u00a0 The results show a clear improvement of cognitive function in PD, without an increase in risk of falls, although the risk of tremor and adverse drug reactions was increased.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Read more at:\u00a0 http:\/\/jnnp.bmj.com\/content\/early\/2014\/09\/15\/jnnp-2014-308764.abstract<\/p>\n<p>&nbsp;<\/p>\n<div id=\"slugline\"><cite> <span id=\"article-slug-jnl-abbr\"> <abbr class=\"slug-jnl-abbrev\" title=\"Journal of Neurology, Neurosurgery &amp; Psychiatry\"> J Neurol Neurosurg <a id=\"FALINK_6_0_5\" class=\"FAtxtL\" href=\"http:\/\/jnnp.bmj.com\/content\/early\/2014\/09\/15\/jnnp-2014-308764.abstract#\">Psychiatry<\/a><\/abbr> <\/span> <span class=\"slug-doi\" title=\"10.1136\/jnnp-2014-308764\"> doi:10.1136\/jnnp-2014-308764 <\/span> <\/cite><\/div>\n<ul class=\"subject-headings last-child\">\n<li>Movement disorders<\/li>\n<\/ul>\n<ul class=\"series-titles\">\n<li>Research paper<\/li>\n<\/ul>\n<div class=\"article abstract-view \">\n<h1 id=\"article-title-1\">Cholinesterase inhibitors for Parkinson&#8217;s disease: a systematic review and meta-analysis<\/h1>\n<div class=\"contributors\">\n<ol id=\"contrib-group-1\" class=\"contributor-list\">\n<li id=\"contrib-1\" class=\"contributor\"><span class=\"name\"><a class=\"name-search\" href=\"http:\/\/jnnp.bmj.com\/search?author1=Gennaro+Pagano&amp;sortspec=date&amp;submit=Submit\">Gennaro Pagano<\/a><\/span><a id=\"xref-aff-1-1\" class=\"xref-aff\" href=\"http:\/\/jnnp.bmj.com\/content\/early\/2014\/09\/15\/jnnp-2014-308764.abstract#aff-1\">1<\/a><span class=\"xref-sep\">,<\/span><a id=\"xref-aff-2-1\" class=\"xref-aff\" href=\"http:\/\/jnnp.bmj.com\/content\/early\/2014\/09\/15\/jnnp-2014-308764.abstract#aff-2\">2<\/a>,<\/li>\n<li id=\"contrib-2\" class=\"contributor\"><span class=\"name\"><a class=\"name-search\" href=\"http:\/\/jnnp.bmj.com\/search?author1=Giuseppe+Rengo&amp;sortspec=date&amp;submit=Submit\">Giuseppe Rengo<\/a><\/span><a id=\"xref-aff-3-1\" class=\"xref-aff\" href=\"http:\/\/jnnp.bmj.com\/content\/early\/2014\/09\/15\/jnnp-2014-308764.abstract#aff-3\">3<\/a>,<\/li>\n<li id=\"contrib-3\" class=\"contributor\"><span class=\"name\"><a class=\"name-search\" href=\"http:\/\/jnnp.bmj.com\/search?author1=Giuseppe+Pasqualetti&amp;sortspec=date&amp;submit=Submit\">Giuseppe Pasqualetti<\/a><\/span><a id=\"xref-aff-4-1\" class=\"xref-aff\" href=\"http:\/\/jnnp.bmj.com\/content\/early\/2014\/09\/15\/jnnp-2014-308764.abstract#aff-4\">4<\/a>,<\/li>\n<li id=\"contrib-4\" class=\"contributor\"><span class=\"name\"><a class=\"name-search\" href=\"http:\/\/jnnp.bmj.com\/search?author1=Grazia+Daniela+Femminella&amp;sortspec=date&amp;submit=Submit\">Grazia Daniela Femminella<\/a><\/span><a id=\"xref-aff-2-2\" class=\"xref-aff\" href=\"http:\/\/jnnp.bmj.com\/content\/early\/2014\/09\/15\/jnnp-2014-308764.abstract#aff-2\">2<\/a>,<\/li>\n<li id=\"contrib-5\" class=\"contributor\"><span class=\"name\"><a class=\"name-search\" href=\"http:\/\/jnnp.bmj.com\/search?author1=Fabio+Monzani&amp;sortspec=date&amp;submit=Submit\">Fabio Monzani<\/a><\/span><a id=\"xref-aff-4-2\" class=\"xref-aff\" href=\"http:\/\/jnnp.bmj.com\/content\/early\/2014\/09\/15\/jnnp-2014-308764.abstract#aff-4\">4<\/a>,<\/li>\n<li id=\"contrib-6\" class=\"contributor\"><span class=\"name\"><a class=\"name-search\" href=\"http:\/\/jnnp.bmj.com\/search?author1=Nicola+Ferrara&amp;sortspec=date&amp;submit=Submit\">Nicola Ferrara<\/a><\/span><a id=\"xref-aff-2-3\" class=\"xref-aff\" href=\"http:\/\/jnnp.bmj.com\/content\/early\/2014\/09\/15\/jnnp-2014-308764.abstract#aff-2\">2<\/a><span class=\"xref-sep\">,<\/span><a id=\"xref-aff-3-2\" class=\"xref-aff\" href=\"http:\/\/jnnp.bmj.com\/content\/early\/2014\/09\/15\/jnnp-2014-308764.abstract#aff-3\">3<\/a>,<\/li>\n<li id=\"contrib-7\" class=\"last\"><span class=\"name\"><a class=\"name-search\" href=\"http:\/\/jnnp.bmj.com\/search?author1=Michele+Tagliati&amp;sortspec=date&amp;submit=Submit\">Michele Tagliati<\/a><\/span><a id=\"xref-aff-5-1\" class=\"xref-aff\" href=\"http:\/\/jnnp.bmj.com\/content\/early\/2014\/09\/15\/jnnp-2014-308764.abstract#aff-5\">5<\/a><\/li>\n<\/ol>\n<\/div>\n<\/div>\n<p><!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cholinesterase inhibitors (ChIs) improve cholinergic transmission and thereby may lead to improved cognitive function in PD, although the risk of side-effects such as falls may be potentially increased.\u00a0 In an upcoming issue of JNNP (On line first)\u00a0 Pagano and colleagues conducted a meta-analysis to further assess these issues.\u00a0 The results show a clear improvement of [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":160,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-466","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cholinesterase inhibitors in Parkinsons disease? - JNNP blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cholinesterase inhibitors in Parkinsons disease? - JNNP blog\" \/>\n<meta property=\"og:description\" content=\"Cholinesterase inhibitors (ChIs) improve cholinergic transmission and thereby may lead to improved cognitive function in PD, although the risk of side-effects such as falls may be potentially increased.\u00a0 In an upcoming issue of JNNP (On line first)\u00a0 Pagano and colleagues conducted a meta-analysis to further assess these issues.\u00a0 The results show a clear improvement of [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"JNNP blog\" \/>\n<meta property=\"article:published_time\" content=\"2014-10-08T11:20:48+00:00\" \/>\n<meta name=\"author\" content=\"Steve Vucic, Web Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Vucic, Web Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/10\\\/08\\\/cholinesterase-inhibitors-in-parkinsons-disease\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/10\\\/08\\\/cholinesterase-inhibitors-in-parkinsons-disease\\\/\"},\"author\":{\"name\":\"Steve Vucic, Web Editor\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#\\\/schema\\\/person\\\/5b9f797a427758da9d63182166e6458c\"},\"headline\":\"Cholinesterase inhibitors in Parkinsons disease?\",\"datePublished\":\"2014-10-08T11:20:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/10\\\/08\\\/cholinesterase-inhibitors-in-parkinsons-disease\\\/\"},\"wordCount\":134,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/10\\\/08\\\/cholinesterase-inhibitors-in-parkinsons-disease\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/10\\\/08\\\/cholinesterase-inhibitors-in-parkinsons-disease\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/10\\\/08\\\/cholinesterase-inhibitors-in-parkinsons-disease\\\/\",\"name\":\"Cholinesterase inhibitors in Parkinsons disease? - JNNP blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#website\"},\"datePublished\":\"2014-10-08T11:20:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/10\\\/08\\\/cholinesterase-inhibitors-in-parkinsons-disease\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/10\\\/08\\\/cholinesterase-inhibitors-in-parkinsons-disease\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/10\\\/08\\\/cholinesterase-inhibitors-in-parkinsons-disease\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cholinesterase inhibitors in Parkinsons disease?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/\",\"name\":\"JNNP blog\",\"description\":\"The official JNNP blog. A place to discuss wider neurology beyond the journal&#039;s monthly edition.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#organization\",\"name\":\"JNNP blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/files\\\/2017\\\/11\\\/blog-logo-jnnp1.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/files\\\/2017\\\/11\\\/blog-logo-jnnp1.png\",\"width\":427,\"height\":34,\"caption\":\"JNNP blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#\\\/schema\\\/person\\\/5b9f797a427758da9d63182166e6458c\",\"name\":\"Steve Vucic, Web Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g\",\"caption\":\"Steve Vucic, Web Editor\"},\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/author\\\/svucic\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cholinesterase inhibitors in Parkinsons disease? - JNNP blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/","og_locale":"en_US","og_type":"article","og_title":"Cholinesterase inhibitors in Parkinsons disease? - JNNP blog","og_description":"Cholinesterase inhibitors (ChIs) improve cholinergic transmission and thereby may lead to improved cognitive function in PD, although the risk of side-effects such as falls may be potentially increased.\u00a0 In an upcoming issue of JNNP (On line first)\u00a0 Pagano and colleagues conducted a meta-analysis to further assess these issues.\u00a0 The results show a clear improvement of [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/","og_site_name":"JNNP blog","article_published_time":"2014-10-08T11:20:48+00:00","author":"Steve Vucic, Web Editor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Steve Vucic, Web Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/"},"author":{"name":"Steve Vucic, Web Editor","@id":"https:\/\/blogs.bmj.com\/jnnp\/#\/schema\/person\/5b9f797a427758da9d63182166e6458c"},"headline":"Cholinesterase inhibitors in Parkinsons disease?","datePublished":"2014-10-08T11:20:48+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/"},"wordCount":134,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/","url":"https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/","name":"Cholinesterase inhibitors in Parkinsons disease? - JNNP blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/#website"},"datePublished":"2014-10-08T11:20:48+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/10\/08\/cholinesterase-inhibitors-in-parkinsons-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jnnp\/"},{"@type":"ListItem","position":2,"name":"Cholinesterase inhibitors in Parkinsons disease?"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jnnp\/#website","url":"https:\/\/blogs.bmj.com\/jnnp\/","name":"JNNP blog","description":"The official JNNP blog. A place to discuss wider neurology beyond the journal&#039;s monthly edition.","publisher":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jnnp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jnnp\/#organization","name":"JNNP blog","url":"https:\/\/blogs.bmj.com\/jnnp\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jnnp\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jnnp\/files\/2017\/11\/blog-logo-jnnp1.png","contentUrl":"https:\/\/blogs.bmj.com\/jnnp\/files\/2017\/11\/blog-logo-jnnp1.png","width":427,"height":34,"caption":"JNNP blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jnnp\/#\/schema\/person\/5b9f797a427758da9d63182166e6458c","name":"Steve Vucic, Web Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g","caption":"Steve Vucic, Web Editor"},"url":"https:\/\/blogs.bmj.com\/jnnp\/author\/svucic\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/posts\/466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/users\/160"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/comments?post=466"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/posts\/466\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/media?parent=466"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/categories?post=466"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/tags?post=466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}